INVA
Innoviva Inc
NASDAQ · Pharmaceuticals
$21.80
+0.23 (+1.07%)
Open$21.56
Previous Close$21.57
Day High$21.92
Day Low$21.56
52W High$22.76
52W Low$16.52
Volume—
Avg Volume780.0K
Market Cap1.63B
P/E Ratio12.80
EPS$1.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+79.6% upside
Current
$21.80
$21.80
Target
$39.16
$39.16
$23.99
$39.16 avg
$41.33
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 361.52M | 372.36M | 318.43M |
| Net Income | 23.57M | 21.85M | 97.42M |
| Profit Margin | 6.5% | 6.2% | 30.6% |
| EBITDA | 191.26M | 187.14M | 169.91M |
| Free Cash Flow | — | — | 81.64M |
| Rev Growth | -2.9% | -2.9% | +17.6% |
| Debt/Equity | 0.65 | 0.65 | 0.61 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |